2019
DOI: 10.1016/j.molcel.2018.12.001
|View full text |Cite
|
Sign up to set email alerts
|

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

Abstract: Graphical Abstract Highlights d Proximity proteomics of WT and MT Ras find new interactors and cellular functions d Proteomic integration with CRISPR genetics identifies mTOR as Ras-proximal protein d Mutant Ras directly binds and activates mTORC2 d Disrupting the MT Ras-mTORC2 interaction impedes Ras tumorigenesis in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
134
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(147 citation statements)
references
References 60 publications
12
134
1
Order By: Relevance
“…Similarly, we did not find evidence of Ras pathwayassociated proteins or GTPases in our proximal biotin labeling experiments. These findings are consistent with Ras-centric proteomic studies that have not identified RASSF proteins as endogenous interactors of either wild type or mutant Ras proteins 51 . Instead, we here define the RASSF2-proximal proteome in leukemia cells and demonstrate the critical importance of its endogenous interaction with Hippo kinases, MST1 and MST2, through the C-terminal SARAH domain.…”
Section: Discussionsupporting
confidence: 89%
“…Similarly, we did not find evidence of Ras pathwayassociated proteins or GTPases in our proximal biotin labeling experiments. These findings are consistent with Ras-centric proteomic studies that have not identified RASSF proteins as endogenous interactors of either wild type or mutant Ras proteins 51 . Instead, we here define the RASSF2-proximal proteome in leukemia cells and demonstrate the critical importance of its endogenous interaction with Hippo kinases, MST1 and MST2, through the C-terminal SARAH domain.…”
Section: Discussionsupporting
confidence: 89%
“…This suggests that either Hras Q61L is not as oncogenic as Kras Q61L or the encoded protein is expressed too low (or high) to be tumorigenic. In support of the first, RAS isoforms differ in their residency at different membranes 50 and the composition of proteins within the immediate vicinity differs between RAS isoforms 51,52 , with proteins like PIP5K1A 52 , calmodulin 53 , galectin-3 54 , and so forth documented to specifically associate with KRAS. In support of the second, a Kras allele whereby the 3ʹ end was replaced with Hras exons to encode Hras protein was found mutated in urethane-induced tumors 55 , indicating that under a Kras promoter Hras Q61L is indeed oncogenic in the lung.…”
Section: Discussionmentioning
confidence: 94%
“…Another interesting finding is that the positively charged amino acid cluster KKGK motif at the juxtamembrane region of CD146 is essential for CD146-mediated mTORC2 activation by GFs, although direct visualization of the PM-associated CD146-Rictor is not applicable, because of unavailability of suitable antibodies. Recently, it has been identified that oncogenic active Ras binds and stimulates mTORC2 (Kovalski et al, 2019). Given that all Ras proteins contain similar positively charged amino acid clusters in their hypervariable region, which is in a close vicinity to the PM anchor site (Simanshu et al, 2017), it is plausible that oncogenic Ras stimulates mTORC2 by binding to Rictor through these clusters.…”
Section: Discussionmentioning
confidence: 99%